Olverembatinib is a targeted therapy for specific types of leukemia. Common side effects include hematological abnormalities (e.g., anemia, thrombocyt···【Read More】
Update: 2026-01-19Source: Haiou HealthViews: 78
The daily dosage of olverembatinib must be strictly followed as directed by a physician, typically 40 mg once daily (the specific dosage shall be subj···【Read More】
Update: 2026-01-19Source: Haiou HealthViews: 91
Olverembatinib is a targeted therapy agent primarily indicated for adult patients with chronic myeloid leukemia (CML) or acute lymphoblastic leukemia ···【Read More】
Update: 2026-01-19Source: Haiou HealthViews: 78
Olverembatinib is a targeted therapy drug indicated for patients with specific types of leukemia, with olverembatinib as its primary active ingredient···【Read More】
Update: 2026-01-19Source: Haiou HealthViews: 78
The contraindications of pyrotinib mainly involve hypersensitivity to drug components, severe hepatic or renal insufficiency, pregnant and lactating w···【Read More】
Update: 2026-01-19Source: Haiou HealthViews: 75
Pyrotinib Maleate is an oral targeted therapy drug primarily indicated for the treatment of HER2-positive breast cancer. Administration must be strict···【Read More】
Update: 2026-01-19Source: Haiou HealthViews: 76
Pyrotinib is a small-molecule targeted drug primarily indicated for the treatment of HER2-positive breast cancer. Its common adverse reactions mainly ···【Read More】
Update: 2026-01-19Source: Haiou HealthViews: 77
The dosage of pyrotinib must strictly follow the doctor's instructions and is usually adjusted based on the patient's body weight, disease con···【Read More】
Update: 2026-01-19Source: Haiou HealthViews: 79
Pyrotinib is a small-molecule tyrosine kinase inhibitor (TKI), primarily indicated for the treatment of patients with HER2-positive breast cancer. Cur···【Read More】
Update: 2026-01-19Source: Haiou HealthViews: 96
Pyrotinib is an oral small-molecule tyrosine kinase inhibitor (TKI) primarily indicated for the treatment of HER2-positive breast cancer. It irreversi···【Read More】
Update: 2026-01-19Source: Haiou HealthViews: 78
Anlotinib is an oral multi-targeted tyrosine kinase inhibitor, primarily indicated for the targeted therapy of specific advanced cancers. To balance t···【Read More】
Update: 2026-01-16Source: Haiou HealthViews: 78
Anlotinib is an anti-tumor targeted drug. Its common adverse reactions include hypertension, bleeding risk, hand-foot syndrome, proteinuria, and gastr···【Read More】
Update: 2026-01-16Source: Haiou HealthViews: 78
The recommended dosage of anlotinib is 12 mg once daily, to be administered orally on an empty stomach (no food should be consumed 2 hours before and ···【Read More】
Update: 2026-01-16Source: Haiou HealthViews: 90
Anlotinib is an oral small-molecule multi-targeted tyrosine kinase inhibitor, primarily indicated for the treatment of patients with specific advanced···【Read More】
Update: 2026-01-16Source: Haiou HealthViews: 80
Anlotinib Hydrochloride Capsules is an antineoplastic agent belonging to the class of multi-targeted receptor tyrosine kinase inhibitors. It exerts it···【Read More】
Update: 2026-01-16Source: Haiou HealthViews: 79
Copyright 2024 @ haiouhealth.com All right reserved SEAGULL HEALTH



